Cite

HARVARD Citation

    Glicksman, R. et al. (n.d.). 97: Four-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated with Ablative Therapies: The Sprat Analysis. Radiotherapy and oncology. pp. S43-. [Online]. 
  
Back to record